Chronic cannabinoid CB(2) activation reverses paclitaxel neuropathy without tolerance or CB(1)-dependent withdrawal

BACKGROUND: Mixed cannabinoid CB(1)/CB(2) agonists such as Δ(9)-tetrahydrocannabinol (Δ(9)-THC) can produce tolerance, physical withdrawal, and unwanted CB(1)-mediated central nervous system side effects. Whether repeated systemic administration of a CB(2)-preferring agonist engages CB(1) receptors...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Deng, Liting, Guindon, Josée, Cornett, Benjamin L., Makriyannis, Alexandros, Mackie, Ken, Hohmann, Andrea G.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4209205/
https://ncbi.nlm.nih.gov/pubmed/24853387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biopsych.2014.04.009
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados